Drugs / Seasonal cell-derived influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00599443 | Oct 2007 → May 2008 | — | Solvay Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seasonal cell-derived influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00599443 ↗ |
| Modality | Vaccine | “trivalent cell-derived influenza vaccine” NCT00599443 ↗ |
| Route | Intramuscular | “administered by intramuscular injection” NCT00599443 ↗ |